Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Bernardi

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|June 4, 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemiaAlessandro Bruno, Francesca Lorentino, Matteo G Carrabba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2015
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem CellsNicoletta Cieri, Raffaella Greco, Lara Crucitti, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
Blood Cancer Journal|November 14, 2020
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07Renato Bassan, Chiara Pavoni, Tamara Intermesoli, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Nature Communications|March 8, 2023
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemiaMatteo Maria Naldini, Gabriele Casirati, Matteo Barcella, et al.
Blood|July 23, 2008
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantationLuca Vago, Barbara Forno, Maria Pia Sormani, et al.
American Journal of Hematology|April 23, 2013
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeEmilio Paolo Alessandrino, Matteo G Della Porta, Luca Malcovati, et al.
Blood|February 22, 2014
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-RMatteo G Della Porta, Emilio Paolo Alessandrino, Andrea Bacigalupo, et al.
Bone Marrow Transplantation|January 14, 2018
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patientsRaffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|June 4, 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemiaAlessandro Bruno, Francesca Lorentino, Matteo G Carrabba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2015
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem CellsNicoletta Cieri, Raffaella Greco, Lara Crucitti, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
Blood Cancer Journal|November 14, 2020
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07Renato Bassan, Chiara Pavoni, Tamara Intermesoli, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Nature Communications|March 8, 2023
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemiaMatteo Maria Naldini, Gabriele Casirati, Matteo Barcella, et al.
Blood|July 23, 2008
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantationLuca Vago, Barbara Forno, Maria Pia Sormani, et al.
American Journal of Hematology|April 23, 2013
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeEmilio Paolo Alessandrino, Matteo G Della Porta, Luca Malcovati, et al.
Blood|February 22, 2014
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-RMatteo G Della Porta, Emilio Paolo Alessandrino, Andrea Bacigalupo, et al.
Bone Marrow Transplantation|January 14, 2018
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patientsRaffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, et al.
Pageof 10